(g) Schematic representation of how combined treatment of non-metastatic MYC-HCC can now induce metastases and synergistic inhibition of Ccl2 and Il13 can inhibit metastasis of MYC/Twist1-HCC. This evidence concerns the gene CCL2 and hepatocellular carcinoma.